Role of Individual MARK Isoforms in Phosphorylation of Tau at Ser262 in Alzheimer's Disease

被引:60
|
作者
Gu, Gucci Jijuan [1 ]
Lund, Harald [2 ,3 ,4 ]
Wu, Di [1 ]
Blokzijl, Andries [1 ]
Classon, Christina [1 ]
von Euler, Gabriel [2 ,3 ,4 ]
Landegren, Ulf [1 ]
Sunnemark, Dan [2 ,3 ,4 ]
Kamali-Moghaddam, Masood [1 ]
机构
[1] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden
[2] CNS, IMed, Dept Neurosci, Sodertalje, Sweden
[3] AstraZeneca Res & Dev, S-15185 Sodertalje, Sweden
[4] Karolinska Inst, Dept Clin Neurosci, Ctr Mol Med L8 04, S-17176 Stockholm, Sweden
基金
瑞典研究理事会;
关键词
Alzheimer's disease; MARK; Phosphorylation; Proximity ligation; Tau; AFFINITY-REGULATING KINASE; PROTEIN; BINDING; TANGLES; FAMILY;
D O I
10.1007/s12017-013-8232-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The microtubule-affinity regulating kinase (MARK) family consists of four highly conserved members that have been implicated in phosphorylation of tau protein, causing formation of neurofibrillary tangles in Alzheimer's disease (AD). Understanding of roles by individual MARK isoform in phosphorylating tau has been limited due to lack of antibodies selective for each MARK isoform. In this study, we first applied the proximity ligation assay on cells to select antibodies specific for each MARK isoform. In cells, a CagA peptide specifically and significantly inhibited tau phosphorylation at Ser(262) mediated by MARK4 but not other MARK isoforms. We then used these antibodies to study expression levels of MARK isoforms and interactions between tau and individual MARK isoforms in postmortem human brains. We found a strong and significant elevation of MARK4 expression and MARK4-tau interactions in AD brains, correlating with the Braak stages of the disease. These results suggest the MARK4-tau interactions are of functional importance in the progression of AD and the results also identify MARK4 as a promising target for AD therapy.
引用
收藏
页码:458 / 469
页数:12
相关论文
共 50 条
  • [41] GSK3β phosphorylation catalyzes the aggregation of tau into Alzheimer's disease- like filaments
    Chakraborty, Pijush
    Purslow, Jeffrey A.
    Fromm, Simon A.
    Chatterjee, Debdeep
    Zachrdla, Milan
    Zhuang, Shannon
    Puri, Sambhavi
    Wolozin, Benjamin
    Zweckstetter, Markus
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (52)
  • [42] Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer's disease continuum
    Gobom, Johan
    Benedet, Andrea L.
    Mattsson-Carlgren, Niklas
    Montoliu-Gaya, Laia
    Schultz, Nina
    Ashton, Nicholas J.
    Janelidze, Shorena
    Servaes, Stijn
    Sauer, Mathias
    Pascoal, Tharick A.
    Karikari, Thomas K.
    Lantero-Rodriguez, Juan
    Brinkmalm, Gunnar
    Zetterberg, Henrik
    Hansson, Oskar
    Rosa-Neto, Pedro
    Blennow, Kaj
    MOLECULAR NEURODEGENERATION, 2022, 17 (01)
  • [43] Alzheimer's Disease-Specific Tau Phosphorylation is Induced by Herpes Simplex Virus Type 1
    Wozniak, Matthew A.
    Frost, Alison L.
    Itzhaki, Ruth F.
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (02) : 341 - 350
  • [44] Targeting Abnormal Tau Phosphorylation for Alzheimer's Therapeutics
    Singh, Aditya
    Ansari, Vaseem Ahamad
    Mahmood, Tarique
    Hasan, Syed Misbahul
    Wasim, Rufaida
    Maheshwari, Shubhrat
    Akhtar, Juber
    Sheikh, Suvaiv
    Vishwakarma, Vishal Kumar
    HORMONE AND METABOLIC RESEARCH, 2024, 56 (07) : 482 - 488
  • [45] Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis
    Ando, Kunie
    Houben, Sarah
    Homa, Megane
    de Fisenne, Marie-Ange
    Potier, Marie-Claude
    Erneux, Christophe
    Brion, Jean-Pierre
    Leroy, Karelle
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2021, 13
  • [46] S6K/p70S6K1 protects against tau-mediated neurodegeneration by decreasing the level of tau phosphorylated at Ser262 in a Drosophila model of tauopathy
    Chiku, Tomoki
    Hayashishita, Motoki
    Saito, Taro
    Oka, Mikiko
    Shinno, Kanako
    Ohtake, Yosuke
    Shimizu, Sawako
    Asada, Akiko
    Hisanaga, Shin-ichi
    Iijima, Koichi M.
    Ando, Kanae
    NEUROBIOLOGY OF AGING, 2018, 71 : 255 - 264
  • [47] Levels of tau phosphorylation at different sites in Alzheimer disease brain
    Ikura, Y
    Kudo, T
    Tanaka, T
    Tanii, H
    Grundke-Iqbal, I
    Iqbal, K
    Takeda, M
    NEUROREPORT, 1998, 9 (10) : 2375 - 2379
  • [48] A role for tau at the synapse in Alzheimer's disease pathogenesis
    Pooler, Amy M.
    Noble, Wendy
    Hanger, Diane P.
    NEUROPHARMACOLOGY, 2014, 76 : 1 - 8
  • [49] The complexity of tau in Alzheimer's disease
    Naseri, Nima N.
    Wang, Hong
    Guo, Jennifer
    Sharma, Manu
    Luo, Wenjie
    NEUROSCIENCE LETTERS, 2019, 705 : 183 - 194
  • [50] A state of delirium: Deciphering the effect of inflammation on tau pathology in Alzheimer's disease
    Barron, Matthew
    Gartlon, Jane
    Dawson, Lee A.
    Atkinson, Peter J.
    Pardon, Marie-Christine
    EXPERIMENTAL GERONTOLOGY, 2017, 94 : 103 - 107